COMMUNIQUÉS West-GlobeNewswire

Pascal Biosciences Announces Year-End Investor Update Webcast
11/12/2018
Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific VANCOUVER, British Columbia and SEATTLE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Pascal [...]
Golden Leaf Holdings announces change in Board of Director composition
11/12/2018
PORTLAND, Ore., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
CERESPIR INCORPORATED et le NATIONAL NEUROSCIENCE INSTITUTE – SINGAPOUR annoncent des données positives montrant les effets bénéfiques du composé Itanapraced de CERESPIR au stade clinique dans un modèle LRRK2 de la maladie de Parkinson
11/12/2018
Itanapraced bloque l'expression de LRRK2 et la neurotoxicité à médiation par LRRK2 Itanapraced est prêt à passer à la Phase 2 chez les patients atteints de la maladie de Parkinson avec ou sans mutation génétique NEW [...]
Wright Medical Group N.V. Announces Payment Date and Record Date for CVR Product Sales Milestone Payment
11/12/2018
AMSTERDAM, The Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced a contingent value right (CVR) milestone payment of US $1.50 per contingent value right (CVR) payable [...]
BELLUS Health Announces Overnight Marketed Equity Offering
10/12/2018
Not for Distribution to United States Newswire Services or for Dissemination in the United States LAVAL, Quebec, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BELLUS Health Inc. (TSX: BLU) (“BELLUS Health” or the “Company”), a [...]
BELLUS Santé annonce un placement d’actions ordinaires négocié entre deux séances boursières
10/12/2018
Ne pas distribuer aux agences de transmission américaines ni diffuser aux États-Unis LAVAL, Québec, 10 déc. 2018 (GLOBE NEWSWIRE) -- BELLUS Santé inc. (TSX : BLU) (« BELLUS Santé » ou la « société »), une société [...]
National Research Corporation Declares Special and Quarterly Dividend
10/12/2018
Lincoln, Nebraska, Dec. 10, 2018 (GLOBE NEWSWIRE) -- image002 National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a special dividend of fifty cents ($0.50) per share to [...]
John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman
10/12/2018
MORRISVILLE, N.C., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that John M. Dineen has been appointed to the [...]
Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
10/12/2018
Dosing has begun in a randomized study of CPI-1205 / enzalutamide combination versus enzalutamide alone in second-line mCRPC Single-arm CPI-1205 / abiraterone / prednisone combination added to potentially address low [...]
MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease
10/12/2018
IRVINE, Calif. , Dec. 10, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation, ablation and gene therapy, today announced participation in [...]
Wright Medical Group N.V. to Present at 37th Annual J.P. Morgan Healthcare Conference
10/12/2018
Monday, January 7, 2019 at 1:30 p.m. Pacific Time AMSTERDAM, The Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the 37 th Annual J.P. [...]
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments
10/12/2018
-- F iscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Signed Project Expansion Orders for $6.3 Million with Current Customers -- -- Successfully Executed Scheduled Broad Scale Facilities Maintenance [...]
CohBar Appoints Philippe P. Calais, Pharm.D., Ph.D. as Interim Chief Executive Officer
10/12/2018
Company to Host Conference Call on Tuesday, December 11, 2018, at 5:00 pm Eastern Time MENLO PARK, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder
10/12/2018
reSET-O TM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics is leading the development of a new therapeutic class with two FDA-authorized PDTs and a [...]
Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Management and Employees in Genmab
10/12/2018
Company Announcement Copenhagen, Denmark; December 10, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 80,380 restricted stock units to members of the board [...]
Santhera's Board of Directors Submits Amended Proposal to its Extraordinary General Meeting on December 11, 2018
10/12/2018
Pratteln, Switzerland, December 10, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that its Board of Directors will submit an amended proposal to its upcoming Extraordinary General Meeting on December 11, 2018. [...]
SunGen Pharma Receives US FDA Approval for Prednisone ANDA
10/12/2018
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]
Synergy CHC Corp. Announces Insider Buying
10/12/2018
Westbrook, Maine, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, announced today that Synergy’s CEO and Chairman, Jack Ross [...]
OSE Immunotherapeutics Invited to Present Mechanistic Data on Clinical Stage Anti-Interleukin-7 Receptor Antagonist OSE-127 at Two International Scientific Conferences
10/12/2018
Data presented at the Annual World Congress of Digestive Disease in Rome, Nov. 30 - Dec. 2, and at the Antigen-Specific Immune Tolerance Europe Summit in London, Dec. 10 - 12 Presentations highlight OSE-127's [...]

Pages